Singapore to Check Tamiflu after UK based Cochrane Collaboration Report on Tamiflu

Singapore to Check Tamiflu after UK based Cochrane Collaboration Report on Tamif

The Ministry of Health in Singapore has planned to start an investigation regarding the positive impact of Roche AG’s Tamiflu and GSK’s Relenza in controlling flu. UK based non-profit organization Cochrane Collaboration had reported earlier this week that tamiflu and relenza were not found effective after their reviewed 170,000 pages of clinical trial data.

Ministry of Health, Singapore confirmed that the government had stockpiled antiviral drugs Tamiflu and Relenza to control any outbreak of influenza in future. However, the government has now planned to investigate the role of anti-viral medication in control of the symptoms of flu.

As Singapore has planned to carry out an independent study, Roche and GlaxoSmithKline management might have to answer tough questions. The action from Singapore could prompt other governments to take action as well.

In response to the Cochrane Collaboration study, Roche AG’s UK medical director Dr Daniel Thurley said that the company stands by its clinical trial results. He added that the drug has been approved by majority of health regulators across the world, including the World Health Organization. GSK has not yet responded to the findings of the Cochrane Collaboration study.

During a press event in London, Study co-author Carl Heneghan, professor of evidence-based medicine at the University of Oxford said that the governments in various countries have wasted money on stockpiling tamiflu and relenza. Another report appeared in media yesterday saying that U.S. FDA was already aware that tamiflu was not much effective in cases of flu.

The US government spent $1.3 billion on flu medications while UK government spent $700 million on stockpiling after the outbreak of H1N1.


User login



You May Have Missed...

New York Chief Judge to introduce bill to change state's grand jury proceedings
Wed, 02/18/2015 - 09:10

On Tuesday, Chief Judge Jonathan Lippman of the New York Court of Appeals proposed to give courts an unprecedented authority over grand jury...


Nigeria Update

World Malaria Day Draws Attention over Need for Renewed Commitment
Sat, 04/26/2014 - 12:48

The world commemorated the Annual Malaria Day on April 25 and the attention was drawn towards...


Economy Watch

Euro-Area
Wed, 02/04/2015 - 03:22

Euro-area companies have increased hiring as manufacturing and services activity from Germany to...


Health Tonight

New study on penis size may provide answers to men
Thu, 03/05/2015 - 13:39

A new study asking "Am I Normal?" analyzed penis size for 15,000 men and it reveals that a...


Science Tonight

Mathematicians mark Pi Day
Sun, 03/15/2015 - 13:53

Mathematicians around the world are celebrating the unique Pi Day, which marks the discovery of...


UK News

Ball looking forward to buy Rexam
Thu, 02/19/2015 - 09:16

US packaging company Ball is approaching a deal to buy British drinks can maker Rexam. The...


Pharmaceuticals

Astrazeneca’s Experimental Drug to Treat COPD Fails to Reduce Acute Exacerbation
Mon, 09/08/2014 - 13:17

On Monday, AstraZeneca PLC announced that Phase IIa study of benralizumab, an experimental drug...


US News

Astronomers witness Multiple-Star System in Initial Stage of Formation
Sun, 03/15/2015 - 05:08

Astronomers said that for the first time they have observed a multiple-star system in the first...


Technology Tonight

Barack Obama
Fri, 02/13/2015 - 08:59

It is highly probable that the President Barack Obama will announce a new plan with regard to...